In a recent achievement, DP Technology's hit discovery platform RiDYMO® has successfully designed a cyclic peptide targeting ...
RiDYMO® has been successfully employed in various drug discovery programs, including the development of small molecule ...
PARIS and MONHEIM, Germany, Jan. 10, 2025 /PRNewswire/ -- Iktos, a leader in Artificial Intelligence (AI) and Robotics for drug design, and Cube Biotech, a pioneer in membrane protein production and ...
Insilico Medicine (‘Insilico’), a clinical-stage generative artificial intelligence (AI)-driven drug discovery and ...
Absci Corporation (NASDAQ: ABSI), a data-first generative AI drug creation company, and Owkin, a TechBio that uses agentic AI to unlock complex targets for drug discovery, development, and diagnostics ...
Ebola virus, one of the deadliest pathogens, has a fatality rate of about 50%, posing a serious threat to global health and ...
The starting point for all structure-based design work, whether ligand or protein based, is the choice of a suitable target. Antimicrobial-drug targets should be essential, have a unique function ...
The FDA granted orphan drug designation to amezalpat in hepatocellular carcinoma based on phase 1b/2 data showing efficacy ...
Gain Therapeutics' GT-02287 shows promise in treating Parkinson's disease, with positive results and potential for market ...
By combining diverse datasets and powerful analytical and modeling tools, drug developers are finding more potential ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback